IsoPlexis (IsoPlexis) Operating Cash Flow per Share : $-2.46 (TTM As of Dec. 2022)

View and export this data going back to 2021. Start your Free Trial

What is IsoPlexis Operating Cash Flow per Share?

IsoPlexis's operating cash flow per share for the three months ended in Dec. 2022 was $-0.39. IsoPlexis's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2022 was $-2.46.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -85.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for IsoPlexis's Operating Cash Flow per Share or its related term are showing as below:

ISO' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -85.5 Med: -85.5 Max: -85.5
Current: -85.5

During the past 4 years, IsoPlexis's highest 3-Year average Operating Cash Flow per Share Growth Rate was -85.50% per year. The lowest was -85.50% per year. And the median was -85.50% per year.

ISO's 3-Year OCF Growth Rate is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 2.55 vs ISO: -85.50

IsoPlexis Operating Cash Flow per Share Historical Data

The historical data trend for IsoPlexis's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IsoPlexis Operating Cash Flow per Share Chart

IsoPlexis Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Operating Cash Flow per Share

-0.39

-10.46

-8.45

-2.46

IsoPlexis Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22
Operating Cash Flow per Share	Get a 7-Day Free Trial								-0.71	-0.82	-0.83	-0.43	-0.39

Competitive Comparison of IsoPlexis's Operating Cash Flow per Share

For the Medical Devices subindustry, IsoPlexis's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

IsoPlexis's Price-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, IsoPlexis's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where IsoPlexis's Price-to-Operating-Cash-Flow falls into.

IsoPlexis Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

IsoPlexis's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2022 is calculated as

Operating Cash Flow per Share (A: Dec. 2022 )	=	Cash Flow from Operations (A: Dec. 2022 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2022 )
	=	-96.642	/	39.318
	=	-2.46

IsoPlexis's Operating Cash Flow per Share for the quarter that ended in Dec. 2022 is calculated as

Operating Cash Flow per Share (Q: Dec. 2022 )	=	Cash Flow from Operations (Q: Dec. 2022 )	/	Shares Outstanding (Diluted Average) (Q: Dec. 2022 )
	=	-15.478	/	39.590
	=	-0.39

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.46

IsoPlexis Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of IsoPlexis's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

IsoPlexis (IsoPlexis) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » IsoPlexis Corp (NAS:ISO) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

35 North East Industrial Road, Branford, CT, USA, 06405

Website

https://www.isoplexis.com

IsoPlexis Corp is a developer of a single-cell detection system designed to accelerate insights in the field of cancer. It designed a platform to reveal functional protein biology and cellular signaling networks at single-cell resolution to accelerate the development of advanced medicines.

Executives

Nachum Shamir	director	12212 TECHNOLOGY BLVD, AUSTIN TX 78727
John Strahley	officer: Chief Financial Officer	35 NORTH EAST INDUSTRIAL ROAD, BRANFORD CT 06405
Sean Mackay	director, officer: Chief Executive Officer	35 NORTH EAST INDUSTRIAL ROAD, BRANFORD CT 06405
Rew Richard W. Ii	officer: SVP, GC & Secretary	7000 WEST WILLIAM CANNON, BUILDING ONE, AUSTIN TX 78735
James R Heath	director	C/O ISOPLEXIS, 35 NE INDUSTRIAL RD, BRANFORD CT 06405
Michael Egholm	director	1 FRANKLIN STREET, UNIT 3104, BOSTON MA 02110
Siddhartha Kadia	director	7475 LUSK BOULEVARD, SAN DIEGO CA 92121
Jason W. Myers	director	C/O ARCHERDX, INC., 2477 55TH STREET, SUITE 202, BOULDER CO 80301
John G. Conley	director	396 GREAT MEADOWS RD, CONCORD MA 01742-1803
Gregory P. Ho	director, 10 percent owner	C/O SPRING MOUNTAIN CAPITAL, LP, 650 MADISON AVENUE, 20TH FLOOR, NEW YORK NY 10022
Peter Siesel	officer: Chief Commercial Officer	35 NORTH EAST INDUSTRIAL ROAD, BRANFORD CT 06405
Jing Zhou	officer: Chief Scientific Officer	35 NORTH EAST INDUSTRIAL ROAD, BRANFORD CT 06405
Rajesh T. Khakhar	officer: VP, Finance	35 NORTH INDUSTRIAL ROAD, BRANFORD CT 06405
Northpond Capital Gp, Llc	10 percent owner	4 BRATTLE STREET, FLOOR 3, CAMBRIDGE MA 02138
Perceptive Life Sciences Master Fund Ltd	10 percent owner	C/O PERCEPTIVE ADVISORS LLC, 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003